These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 28770277

  • 1. Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma.
    Chillón MC, Jiménez C, García-Sanz R, Alcoceba M, Prieto I, García-Alvarez M, Antón A, Maldonado R, Hernández-Ruano M, González M, Gutiérrez NC, Sarasquete ME.
    Ann Hematol; 2017 Oct; 96(10):1699-1705. PubMed ID: 28770277
    [Abstract] [Full Text] [Related]

  • 2. Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma.
    Bang SM, Kim YR, Cho HI, Chi HS, Seo EJ, Park CJ, Yoo SJ, Kim HC, Chun HG, Min HC, Oh BR, Kim TY, Lee JH, Lee DS.
    Cancer Genet Cytogenet; 2006 Jul 15; 168(2):124-32. PubMed ID: 16843102
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma].
    Chen LJ, Li JY, Zhu Y, Wang XW, Qiu HR, Yang RF, Xu W, Xu JR, Lu H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb 15; 26(1):102-5. PubMed ID: 19199264
    [Abstract] [Full Text] [Related]

  • 4. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A, Tabernero MD, Sánchez ML, Pérez de Andrés M, Martín Ayuso M, Hernández J, Moro MJ, Fernández-Calvo J, Sayagués JM, Bortoluci A, San Miguel JF, Orfao A.
    Cancer; 2003 Feb 01; 97(3):601-9. PubMed ID: 12548602
    [Abstract] [Full Text] [Related]

  • 5. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.
    Fonseca R, Oken MM, Harrington D, Bailey RJ, Van Wier SA, Henderson KJ, Kay NE, Van Ness B, Greipp PR, Dewald GW.
    Leukemia; 2001 Jun 01; 15(6):981-6. PubMed ID: 11417487
    [Abstract] [Full Text] [Related]

  • 6. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L, Li J, Xu W, Qiu H, Zhu Y, Zhang Y, Duan L, Qian S, Lu H.
    Exp Oncol; 2007 Jun 01; 29(2):116-20. PubMed ID: 17704743
    [Abstract] [Full Text] [Related]

  • 7. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
    Chang H, Li D, Zhuang L, Nie E, Bouman D, Stewart AK, Chun K.
    Leuk Lymphoma; 2004 May 01; 45(5):965-9. PubMed ID: 15291356
    [Abstract] [Full Text] [Related]

  • 8. Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis.
    Koren-Michowitz M, Hardan I, Berghoff J, Yshoev G, Amariglio N, Rechavi G, Nagler A, Trakhtenbrot L.
    Cancer Lett; 2007 Oct 08; 255(2):307-14. PubMed ID: 17590504
    [Abstract] [Full Text] [Related]

  • 9. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Wu KL, Beverloo B, Lokhorst HM, Segeren CM, van der Holt B, Steijaert MM, Westveer PH, Poddighe PJ, Verhoef GE, Sonneveld P, Dutch-Belgian Haemato-Oncology Cooperative Study Group (HOVON), Dutch Working Party on Cancer Genetics and Cytogenetics (NWCGC).
    Br J Haematol; 2007 Feb 08; 136(4):615-23. PubMed ID: 17223915
    [Abstract] [Full Text] [Related]

  • 10. [Cytogenetic abnormalities and prognosis of 532 patients with multiple myeloma].
    Wu H, Zhang H, He HY, Jiang H, Zhao YY, An R, He J, Li R, Lu J, Hou J.
    Zhonghua Xue Ye Xue Za Zhi; 2017 Sep 14; 38(9):739-743. PubMed ID: 29081188
    [Abstract] [Full Text] [Related]

  • 11. Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.
    Kaufmann H, Krömer E, Nösslinger T, Weltermann A, Ackermann J, Reisner R, Bernhart M, Drach J.
    Eur J Haematol; 2003 Sep 14; 71(3):179-83. PubMed ID: 12930318
    [Abstract] [Full Text] [Related]

  • 12. Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.
    Lai YY, Huang XJ, Cai Z, Cao XS, Chen FP, Chen XQ, Chen BA, Fang MY, Feng JF, Fu WL, Guo HY, Hou M, Hou J, Hu Y, Hu XT, Hu XM, Huang LQ, Jin J, Li JY, Li J, Li W, Liang YM, Liu T, Liu QF, Liu YH, Mao P, Ouyang J, Qiu LG, Qiu L, Shao CK, Shi B, Song YP, Sun ZM, Wang QS, Wang C, Wang JM, Wang YS, Wang Z, Wu JB, Wu YX, Xia RX, Xue YQ, Yang BZ, Yang G, Yang ZL, Yu L, Yuan Z, Zhang S, Zhang Y, Zhao HG, Zhao L, Zhou DB, Zou SH, Zhu YF.
    Chin Med J (Engl); 2012 Aug 14; 125(15):2663-70. PubMed ID: 22931972
    [Abstract] [Full Text] [Related]

  • 13. Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
    Kadam Amare PS, Jain H, Nikalje S, Sengar M, Menon H, Inamdar N, Subramanian PG, Gujral S, Shet T, Epari S, Nair R.
    Indian J Med Res; 2016 Oct 14; 144(4):536-543. PubMed ID: 28256461
    [Abstract] [Full Text] [Related]

  • 14. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
    Königsberg R, Zojer N, Ackermann J, Krömer E, Kittler H, Fritz E, Kaufmann H, Nösslinger T, Riedl L, Gisslinger H, Jäger U, Simonitsch I, Heinz R, Ludwig H, Huber H, Drach J.
    J Clin Oncol; 2000 Feb 14; 18(4):804-12. PubMed ID: 10673522
    [Abstract] [Full Text] [Related]

  • 15. [Genetic abnormalities in multiple myeloma: role in oncogenesis and impact on survival].
    Decaux O, Lodé L, Minvielle S, Avet-Loiseau H.
    Rev Med Interne; 2007 Oct 14; 28(10):677-81. PubMed ID: 17559979
    [Abstract] [Full Text] [Related]

  • 16. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML, Bedell V, Pagel K, Chang KL, Smith D, Somlo G.
    Cancer Genet Cytogenet; 2005 Apr 15; 158(2):99-109. PubMed ID: 15796956
    [Abstract] [Full Text] [Related]

  • 17. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
    Königsberg R, Ackermann J, Kaufmann H, Zojer N, Urbauer E, Krömer E, Jäger U, Gisslinger H, Schreiber S, Heinz R, Ludwig H, Huber H, Drach J.
    Leukemia; 2000 Nov 15; 14(11):1975-9. PubMed ID: 11069034
    [Abstract] [Full Text] [Related]

  • 18. Chromosome 1 abnormalities in multiple myeloma.
    Marzin Y, Jamet D, Douet-Guilbert N, Morel F, Le Bris MJ, Morice P, Abgrall JF, Berthou C, De Braekeleer M.
    Anticancer Res; 2006 Nov 15; 26(2A):953-9. PubMed ID: 16619492
    [Abstract] [Full Text] [Related]

  • 19. Cytogenetics of multiple myeloma.
    Trcić RL, Skelin IK, Sustercić D, Planinc-Peraica A, Ajduković R, Haris V, Kusec R, Begović D.
    Coll Antropol; 2010 Mar 15; 34(1):41-4. PubMed ID: 20432732
    [Abstract] [Full Text] [Related]

  • 20. [The significances of 13q14 deletion for development and prognosis of multiple myeloma].
    Li Q, An G, Li CW, Xu Y, Deng SH, Liu XP, Qi JY, Wang YF, Zou DH, Zhao YZ, Qiu LG.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr 15; 32(4):217-20. PubMed ID: 21569701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.